VEA
ACOR
Virtus ETF Advisers’s Acorda Therapeutics, Inc. ACOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-48,468
| Closed | -$644K | – | 449 |
|
|
2019
Q1 | $644K | Buy |
48,468
+11,357
| +31% | +$151K | 1.37% | 23 |
|
|
2018
Q4 | $578K | Buy |
37,111
+12,262
| +49% | +$191K | 0.1% | 53 |
|
|
2018
Q3 | $488K | Buy |
24,849
+1,674
| +7% | +$32.9K | 0.05% | 127 |
|
|
2018
Q2 | $665K | Sell |
23,175
-20,478
| -47% | -$588K | 0.59% | 117 |
|
|
2018
Q1 | $1.03M | Sell |
43,653
-2,561
| -6% | -$60.5K | 0.9% | 38 |
|
|
2017
Q4 | $991K | Sell |
46,214
-13,789
| -23% | -$296K | 1.24% | 20 |
|
|
2017
Q3 | $1.42M | Hold |
60,003
| – | – | 0.19% | 37 |
|
|
2017
Q2 | $1.18M | Buy |
60,003
+9,984
| +20% | +$197K | 0.18% | 38 |
|
|
2017
Q1 | $1.05M | Buy |
50,019
+4,810
| +11% | +$101K | 0.19% | 63 |
|
|
2016
Q4 | $850K | Buy |
45,209
+21,032
| +87% | +$395K | 0.25% | 79 |
|
|
2016
Q3 | $505K | Buy |
24,177
+3,047
| +14% | +$63.6K | 0.24% | 73 |
|
|
2016
Q2 | $539K | Buy |
21,130
+5,718
| +37% | +$146K | 0.4% | 44 |
|
|
2016
Q1 | $408K | Buy |
+15,412
| New | +$408K | 0.56% | 49 |
|